drugset / Trial / NCT06951087
Intravitreal and Intracameral DEX in NPDR
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate the effects of intravitreal and intracameral injection of dexamethasone during cataract phacoemulsification in patients with mild to moderate non-proliferative diabetic retinopathy
Timeline
- Start
- 2022-01-31
- Primary completion
- 2025-04-20
- Completion
- 2025-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 0.5 mg | Intravitreal |